Results 81 to 90 of about 2,355 (177)

Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool. [PDF]

Curr Oncol
Breakell T, Neri P, Staats LAN, Kramer R, Berking C, Erdmann M, Hartmann A.   +6 more
europepmc   +1 more source

Sustained Repigmentation in Vitiligo and Leukodermas Using Melanocyte–Keratinocyte Transplantation: 7 Years of Data

Clinical, Cosmetic and Investigational Dermatology
Nuttaporn Nuntawisuttiwong,* Punyanut Yothachai,* Teerapat Paringkarn, Chayada Chaiyabutr, Chanisada Wongpraparut, Narumol Silpa-archa Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand&ast ...
Nuntawisuttiwong N, Yothachai P, Paringkarn T, Chaiyabutr C, Wongpraparut C, Silpa-archa N   +5 more
doaj  

Repigmentation and hair regrowth in perinevoid alopecia treated with topical gabapentin: A case for neuromodulation. [PDF]

JAAD Case Rep
Rigatti M, De Bastiani M, Crivelatti I, Cadore D, de Medeiros T.   +4 more
europepmc   +1 more source

The Effectiveness of Home-Based Phototherapy in Vitiligo: A Systematic Review and Meta-Analysis. [PDF]

Photodermatol Photoimmunol Photomed
Xireaili F, Ha H, Liu ZF, Lin L, Hsiao MM, Mar A, Chew C.   +6 more
europepmc   +1 more source

Efficacy and Safety of Small Molecule Inhibitor Therapies for Vitiligo: A Systematic Review. [PDF]

Health Sci Rep
Jafarzadeh A, Darvishi MA, Khosravi M, Roohaninasab M, Goodarzi A.   +4 more
europepmc   +1 more source

Vitiligo as a Failure of Immune Resolution and Tissue Regeneration: From Stress Signals to Targeted Immune Modulation. [PDF]

Clin Rev Allergy Immunol
Pupo Silvestrini AV, Lucas JM, de Barros Cardoso CR, Lopes Badra Bentley MV.   +3 more
europepmc   +1 more source

Psoralene in repigmentation of tuberculoid leprosy.

Indian journal of dermatology, 1990
Photoactivated psoralens were studied in sixty cases of tuberculoid leprosy for the repigmentation of hypopigmented macules. It was observed that in 42 (70%) cases there was significant repigmentation within 6 months of therapy; in 5 (8.33%) cases there was mild to moderate repigmentation and in 13 (22.64%) cases, there was no change.
openaire   +1 more source

Recent Advances in Vitiligo Treatment. [PDF]

Immunotargets Ther
Qiu Y, Su X, Chen J, Jiang S, Tang X, He Y, Liu F.   +6 more
europepmc   +1 more source

Segmental Vitiligo and Somatic Mosaicism: From Pathogenesis to Therapeutics. [PDF]

Ann Dermatol
Oh J, Oh SH.
europepmc   +1 more source

Targeting Oxidative Stress to Treat Vitiligo: Clinical and Molecular Evidence. [PDF]

Biomolecules
Aprile N, Scano S, Bellei B, Marini A, Filoni A.   +4 more
europepmc   +1 more source